The chemistry of natural and synthetic skin barrier lipids

Cosmetic Lipids and the Skin Barrier

Volumn , Issue , 2001, Pages 1-36

  Möller, Hinrich ^a  

^a HENKEL KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26344439148     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Elias PM, Friend DS. The permeability barrier in mammalian epidermis. J Cell Bioi 1975; 65:180-191.
2. Lampe MA, Williams ML, Elias PM. Human epidermal lipids: characterization and modulation during differentiation. J Lipid Res 1983; 24:131-140.
3. Wertz PW, Swartzendruber DC, Abraham W, Madison KC, Downing DT. Essential fatty acids and epidermal integrity. Arch Dermatol1987; 123: 1381a-1384a.
4. Downing DT, Wertz PW, Stewart ME. The role of sebum and epidermal lipids in the cosmetic properties of skin. Int J Cosmetic Sci 1986; 8:115-123.
5. Wertz PW, Swartzendruber DC, Kitko DJ, Medison KC, Downing DT. The role of the corneocyte lipid envelops in cohesion of the stratum corneum. J Invest Dermatol 1989; 93:169-172.
6. Stewart ME, Downing DT, Pochi PE, Strauss JS. The fatty acids ofhuman sebaceous gland phosphatidylcholin. Biochim Biophys Acta 1978; 529:380-386.
7. Nicolaides N. Skin lipids: Their biochemical uniqueness. Science 1974; 186:19-26.
8. Guy R, Ridden C, Kealey T. The improved organ maintenance ofthe human sebaceous gland: modeling in vitro the effects ofepidermal growth factor, androgens, estrogens, 13-cis-retinoic acid, and Phenol red. J Invest Dermatol1996; 106:454-460.
9. Osborne DW, Friberg SE. Role of stratum corneum lipids as moisture retaining agents. J Dispers Sci. Technol1987; 8:173-179.
10. Fulmer AW, Kramer GJ. Stratum corneum abnormalities in surfactant-induced dry scaly skin. J Invest Dermatol 1986; 86:598-602.
11. Bouwstra JA, Thewalt J, Gooris GS, Kitson N. A model membrane approach to epidermal permeability barrier: an X-ray diffraction study. Biochemistry 1997; 36: 1770.
12. Wertz PW, Miethke MC, Long SA, Strauss JS, Downing DT. The composition of the cerarnides from human stratum corneum and from comedones. J Invest Dermatol 1985; 84:410-412.
13. Yardley HJ. Epidermal lipids. Int J Cosmetic Sci 1987; 9:13-19.
14. Friberg SE, Osborne DW. Small angle X-ray diffraction patterns ofstratum corneum and a model structure for its lipids. J Disp Sci Techno1 1985; 6:485-495.
15. Friberg SE. Micells, microemu1sions, liquid crystals, and the structure of stratum corneum lipids. J Soc Cosmet Chem 1990; 41:155-171.
16. Friberg SE, Kayali IH, Margosiak M. Stratum corneum structure and transport properties. Drugs Pharm Sci 1990; 42:29-45.
17. Friberg SE, Suhaimi H, Goldsmith LB, Rhein LL. Stratum corneum lipids in a model structure. J Disp Sci Techno1 1988; 9:371-389.
18. Moore DJ, Rerek ME, Mendelsohn R. Role of cerarnides 2 and 5 in the structure of stratum corneum lipid barrier. Int J Cosmet Sci 1999; 21:353-368.
19. Forslin B, Engstrom S, Engbotrm J, Noden L. 'A novel approach to the understanding of human skin barrier function. J Dermato1 Sci 1997; 14:115-125.
20. Bouwstra JA, Gooris GS, Cheng K, Weerheim A, Bras W, Ponec M. Phase behavior of isolated skin lipids. J Lipid Res 1996; 37:999-1011.
21. Bouwstra JA, Cheng K, Gooris GS, Weerheim A, Ponec M. Role of cerarnide 1 and 2 in stratum corneum lipid organization. Biochim Biophys Acta 1996; 1300:177­ 186.
22. Bouwstra JA, Gooris GS, Dubbelaar FER, Weerheirn AM, Ijzerman AP, Ponec M. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998; 39:186-196.
23. Bouwstra JA, Dubbelaar FER, Gooris GS, Weerheim AM, Ponec M. The role of cerarnide composition in the lipid organization of the skin barrier. Biochim Biophys Acta 1999;1419:127-136.
24. Lieckfeldt R, Villailain J, Gomez-Fernandez JC, Lee G. Diffusivity and structural polymorphism in some model stratum corneum lipid systems. Biochim Biophys Acta 1993; 1151:182-188.
25. Kitson N, Thewalt J, Lafleur M, Bloom M. A model membrane approach to epidermal permeability barrier. Biochemistry 1994; 33:6707-6715.
26. Friberg SE, Kayali I, Rhein LD, Simion FA, Cagan RH. The importance of lipids fot water uptake in stratum corneum. Int J Cosmet Sci 1990; 12:5-12.
27. Motta S, Monti M, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis: role ofcerarnide fractions. Arch Dermatol1994; 130:452-456.
28. Lavrijsen APM, Higounenc IM, Weerheim A, Oestrnann E, Tuinenburg EE, Bodcte HE, Ponec M. Validation of an in vivo extraction method for human stratum corneum cerarnides. Arch Dermato1 Res 1994; 286:495-503.
29. Holleran W, Mao-Qiang M, Gao WN, Menon GK, Elias PM, Feingold KR. Sphingolipids are required for mammalian epidermal barrier function. J Clin Invest 1991; 88: 1338-1345.
30. Lintner K, Mondon P, Girard F, Gibaud C. The effect of synthetic cerarnide-2 on transepidermal water loss after stripping or sodium 1aury1 sulfate treatment: an in vivo study. Int J Cosmet Sci 1997; 19:15-25.
31. Tokimitsu I, Asshi M, Suzuki T. European patent 277 641. 1988. Kao Corporation. CA 1989; 110:101532.
32. Imokawa G, Akasaki S, Kawamata A, Yano S, Takaishi N. Water-retaining function in the stratum corneum and its recovery properties by synthetic pseudocerarnides. J Soc Cosmet 1989; 40:273-285.
33. Lambers IWI, Koger HS. WO 95/29151. 1995. Gist-Brocades BV. CA 1996; 124: 176810.
34. Marsh NL, Elias PM, Holleran WM. Glycosylceramides stimulate murine epidermal proliferation. I Clin Invest 1995; 95:2903-2909.
35. Bektas M, Dullin Y, Wieder T, Kolter T, Sandhoff K, Brossmer R, Ihrig P, Orfanos CE, Geilen CC. Induction of apoptosis by synthetic ceramide analogs in the human keratinocyte cell line HaCat. Exp Dermatol1998; 7:342-349.
36. Kaipia A, Chun S-Y, Eisenhauer K, Hsueh AJW. Tumor necrosis factor-a and its second messenger, ceramide, stimulate apoptosis in cultures of ovarian follicles. Endocrinology 1996; 137:4864-4870.
37. Ghahremani M, Foghi A, Dorrington JH. Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptic mechanism. Gyneco1 Onco1 1998; 70: 275-281.
38. Inokuchi, Kuroda Y, Kosaka S, Fujiwara M. L-Threo-l-phenyl-2-decanoylamino­ I-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats. Acta Biochim Pol 1998; 45:479-492.
39. Sweeny EA, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S, Igarashi Y. Sphingosine and its methylated derivative N, N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer 1996; 66:358­ 366.
40. Gupta AK, Fisher GJ, Elder JT, Nickoloff BI, Voorhees n. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin. J Invest Dermatol 1988; 91:486.
41. Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J Invest Dermatol 1992; 98:269-273.
42. Mathias S, Dressler S, Kenneth A, Kolesnick N. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor a. Proc Natl Acad Sci USA. 1991; 82:10009-10013.
43. Schmidt RR, Escher B. Neuere Erkenntnisse tiber Glycosphingolipide. Fat Sci Technol 1992; 94:534-541.
44. Geilen CC, Wieder T, Orfanos CEo Ceramide signalling: regulatory role in cell proliferation and apoptosis in human epidermis. Arch Dermatol Res 1997; 289:559­ 566.
45. Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, Verdejo P, Feinberg C, Nguyen L, Chandar P. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996; 288:383-390.
46. Davies A, Verdejo P, Feinberg C, Rawlings AV. Increased stratum corneum ceramide levels and improved barrier function following topical treatment with tetra-acetylphytosphingosine. J Invest Dermato1 1996; 106:918.
47. Conti A, Rogers I, Verdejo P, Harding CR, Rawlings AV. Seasonal influence of stratum corneum ceramide 1 fatty acids and the influence of topical essential fatty acids. Int J Cosmet Sci 1996; 18:1-12.
48. Zhang K, Kosturko R, Rawlings AV. Effect of thiols on epidermal ceramide biosynthesis. J Invest Dermatol 1996; 104:687.
49. Harding CR, Watkinson A, Rawlings AV, Scott IR. Review article: Dry skin, moisturization and corneodesmolysis. Int J Cosmet Sci 2000; 22:21-52.
50. Schmidt RR, Baer T, Sandhoff K. German patent 4025330. 1992. BASF. CA 1992; 116:236094.
51. Crawford DNK, Rawlings AV, Scott IR. WO 93/22281. 1993. Unilever NY. CA 1994; 121:57220.
52. Philippe M, Garson JC, Gilard P, Hocquaux M, Hussler G, Leroy F, Mahieu C, Semeria D, Vanlerberghe G. Synthesis of N-2-o1eoylamino-octadecane-l,3-diol: a new cerarnide highly active for the treatment of skin and hair. Int J Cosmet Sci 1995; 17:133-146.
53. Wakita H, Tokura Y, Yaki H, Nishimura K, Furukawa F, Takigawa M. Keratinocyte differentiation is induced by cell-permeant cerarnides and its proliferation is promoted by sphingosine. Arch Dermatol Res 1994; 286:350-354.
54. Möller H, Knörr W, Weuthen M, Guckenbiehl B, Wachter R. Neue Pseudoceramide durch Verknüpfung von speziellen Fettstoffen mit Kohlenhydrat-Derivaten. Fettl Lipid 1997; 99:120-129.
55. Watkins S, Motion K, Rossiter K, Critchley P. Questarnide H-A designed cerarnide analogue. SÖFW-J 1995; 121:228-238.
56. Motion KR, Janousek A, Watkins S. WO 94/07844. 1994, Quest International BV. CA 1994; 121:141205.
57. Theis H, Göring S. Use of sphingolipids in skin care products. SÖFW-J 1995; 121: 343-348.
58. Kawamata A, Yano S, Hattori M, Akazaki S, Irnokawa G, Takishi N. European patent 227994. 1989. Kao Corporation. CA 1987; 107:153944.
59. Critchley P, Rawlings AV, Scott IR. European patent 495624.1992. Unilever. CA 1992; 117:137448.
60. Cho SH, Frew LJ, Chandar P, Medison SA. WO 95/16665. 1995. Unilever. CA 1995; 123:314397.
61. Pillai S, Cho SH, Rawlings AV. U.S. patent 5476661. 1995. Elisabeth Arden Co. CA 1996; 124:97266.
62. Eierdanz H, Busch P, Tesmann H, Knorr W, Wachter R. German patent 4238032. 1992. Henkel KGaA. CA 1994; 121:179102.
63. Möller H, Engels T, Wachter R, Busch P. WO 95/34531. 1995. Henkel KGaA. CA 1995; 123:340959.
64. Möller H, Wachter R, Busch P. WO 95/23807.1995. Henkel KGaA. CA 1995; 123: 256169.
65. Möller H, Wachter R, Busch P. German patent 4403258. 1995. Henkel KGaA. CA 1995; 123:122740.
66. Möller H, Wachter R, Busch P. German patent 4430851. 1995. Henkel KGaA. CA 1996; 124:37369.
67. Möller H, Wachter R, Busch P. WO 95/21851. 1995. Henkel KGaA. CA 1995; 123: 122741.
68. Lockhoff O. Glycolipide als Immunomodulatoren-Synthese und Eigenschaften. Angew Chem 1991; 103:1639-1649.
69. Möller H, Biermann M. German patent 4326958. 1995. Henkel KGaA. CA 1995; 122:196562.
70. Möller H, Biermann M. German patent 4326959. 1995. Henkel KGaA. CA 1995; 122:196561.
71. Möller H, Wachter R. German patent 19523479. 1996. Henkel. KGaA. CA 1996; 125:329282.
72. Weuthen M, Riegels P, Wachter R. WO 95/19366. 1995. Henkel KGaA. CA 1995; 123:199297.
73. Möller H, Wachter R, Busch P. WO 96/01807. 1996. Henkel KGaA. CA 1996; 124: 261613.
74. Pauli M, Pauli G. Glycoceramides-epidermal physiological role. Interest in care cosmetics. Objectivation of their mode of action/functional efficacy on man. SÖFW-J 1995; 121:557-580.
75. Critchley P, Kirsch SE, Rawlings AV, Scott IR. WO 92/06982. 1992. Unilever NY. CA 1992; 117:97093.
76. Möller H, Föster T, Class M. German patent 19748399. 1999. Henkel KGaA. CA 1999; 130:339721.